Intra-Cellular Therapies
ITCI
#1827
Rank
NZ$15.64 B
Marketcap
$147.56
Share price
-0.82%
Change (1 day)
39.27%
Change (1 year)

Market capitalization of Intra-Cellular Therapies (ITCI)

Market cap: NZ$15.64 Billion

As of December 2024 Intra-Cellular Therapies has a market cap of NZ$15.64 Billion. This makes Intra-Cellular Therapies the world's 1827th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Intra-Cellular Therapies from 2013 to 2024

End of year Market Cap

Year Marketcap Change
2024NZ$15.64 B43.53%
2023NZ$10.89 B38.07%
2022NZ$7.89 B26.46%
2021NZ$6.24 B76.03%
2020NZ$3.54 B25.4%
2019NZ$2.82 B203.36%
2018NZ$0.93 B-16.23%
2017NZ$1.11 B18.05%
2016NZ$0.94 B-72.21%
2015NZ$3.39 B410.41%
2014NZ$0.66 B23.21%
2013NZ$0.53 B

End of Day market cap according to different sources

On Dec 21st, 2024 the market cap of Intra-Cellular Therapies was reported to be:

NZ$15.64 Billion
by Nasdaq info icon info icon
NZ$15.64 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
NZ$0.18 B-98.80%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$46.11 M-99.71%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$2.98 B-80.91%๐Ÿ‡บ๐Ÿ‡ธ USA